At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 85 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Marketing, Open-Label, Randomized, Comparative Study Comparing the Usefulness of Dexmedetomidine at the Time of Extubation and Post Extubation Period to Other Sedative Management in Post-Operative Patients
Hospira, now a wholly owned subsidiary of Pfizer·interventional·Posted Apr 27, 2006·Updated Mar 20, 2017
In Brief
A Phase 4 clinical trial evaluating Dexmedetomidine and Propofol for Conscious Sedation. Completed, enrolled 85 participants across 13 sites.
Detailed Summary
The purpose of this study is to assess efficacy and safety of dexmedetomidine at the time of extubation and after extubation, in patients requiring postoperative sedation in the ICU.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConscious Sedation
CountriesJapan
CollaboratorsMaruishi Pharmaceutical
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2005
First PostedApr 2006
Primary CompletionAug 2006
TodayJul 2026
First PostedApr 27, 2006
Enrollment StartNov 1, 2005
Primary CompletionAug 1, 2006
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 20.2 years ago
Interventions
Dexmedetomidinedrug
Propofoldrug